Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...